05.02.04 Turku - As the final phase of the company's efficiency improvement programme, BioTie Therapies Corp. is focusing its operations on Turku. The programme was initiated by the merger between BioTie, Contral Pharma and Carbion at the...
more
23.11.03 Hannover - “New concepts in molecular medicine from Finland and Germany” and possibilities for cooperations were explored by representatives from politics, economy and science at a joint event in October at the trade fair...
more
23.11.03 Helsinki - The Finnish biotechnology company Mobidiag Oy made a joint development agreement with STMic-roelectronics, Geneva, in late October with the goal to create a complete micro-fluidics system for DNA-based diagnostics of...
more
23.11.03 Turku - The Finnish company Juvantia Pharma Ltd., Turku, discovered novel small molecule leads for the somatostatin receptor subtypes 1 and 4 in mid-October. They could be used for the development of therapeutics for peripheral...
more
23.11.03 Espoo - Researchers of the Finnish biotech company Ipsat Therapies in October announced positive results of a phase I clinical trial with their lead product, P1A. The bioengineered beta-lactamase, which is released in the lower...
more
